Form 8-K - Current report:
SEC Accession No. 0001193125-25-028591
Filing Date
2025-02-18
Accepted
2025-02-18 16:03:53
Documents
13
Period of Report
2025-02-11
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d834046d8k.htm   iXBRL 8-K 21541
  Complete submission text file 0001193125-25-028591.txt   142793

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vinc-20250211.xsd EX-101.SCH 2838
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vinc-20250211_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vinc-20250211_pre.xml EX-101.PRE 11250
15 EXTRACTED XBRL INSTANCE DOCUMENT d834046d8k_htm.xml XML 3631
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

EIN.: 833197402 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39244 | Film No.: 25634788
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)